Marginalized communities to benefit from new breast cancer research

Settlement award will fund mobile mammography and free genetic screening


UC Davis Comprehensive Cancer Center will soon have new tools, including a “mammovan,” to improve breast health and early cancer detection in underserved women living in rural communities.

Breast cancer initiatives spearheaded by the cancer center received $10 million from a class-action lawsuit against Wyeth Pharmaceuticals. The lawsuit alleged Wyeth misrepresented the benefits and risks of its hormone replacement therapy medications for women. In cases where money remains after eligible class members receive their claim payments, courts can distribute those funds to charitable causes in what’s referred to as a cy pres award.

To read more, please see the full UCDavis Health InsideOut article